Biotec Services Doubles Temperature-Controlled Processing Capacity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Biotec Services Doubles Temperature-Controlled Processing Capacity


Biotec Services International, a UK-based global provider of temperature-controlled packaging and distribution services for clinical trials, is doubling its capacity with the addition of new processing facilities. The company is increasing its controlled room-temperature storage by 100% and its cold-room storage by 400%. It is also creating a second advanced therapeutic medicinal products facility.

"Feedback from our recent client survey indicated that refrigerated storage at +2°C to +8°C is the range that most suits our partners' requirements, so we are developing our facilities in line with this and also bespoke temperature demands," said Dr. Fiona Withey, CEO of Biotec Services, in a press release. As part of the company's strategic growth plans, it has also acquired land adjacent to the current Biotec Services' facilities, which will be developed in line with client demands. 

Source: Biotec Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here